Patterns of Disease Progression and Outcomes of Inferior ST-Elevation Myocardial Infarction Complicated by

Giulia Botti1,2, Marina Pieri3, Luigi Cappannoli4

  • 1School of Medicine, Vita Salute San Raffaele University, 20132 Milan, Italy.

PubMed

Insights

Cardiogenic shock following inferior ST-elevation myocardial infarction has a 22.3% in-hospital mortality rate. Worsening shock, prolonged CPR, low blood pressure, and elevated lactates predict poor outcomes in these critical patients.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Emergency Medicine

Background:

  • Cardiogenic shock (CS) is a known complication of anterior ST-elevation myocardial infarction (STEMI).
  • Limited data exist on the progression and outcomes of inferior STEMI complicated by CS.
  • This study addresses the knowledge gap regarding inferior STEMI-CS.

Purpose of the Study:

  • To determine the prevalence of cardiogenic shock in inferior STEMI.
  • To analyze disease progression patterns in inferior STEMI-CS.
  • To identify outcomes and mortality predictors in inferior STEMI-CS.

Main Methods:

  • Retrospective analysis of the INSTINCT Registry (2015-2023).
  • Inclusion of consecutive patients with inferior STEMI and subsequent CS.
  • Data collection on CS stage (SCAI), progression, and in-hospital outcomes.

Main Results:

  • 130 patients with inferior STEMI-CS were analyzed (mean age 69.8 years, 31.5% female).
  • In-hospital mortality was 22.3%. Predictors included prolonged CPR, persistent low SBP, and rising lactates.
  • Worsening CS (15.4% of patients) was rare but associated with significantly higher mortality and complications.

Conclusions:

  • Inferior STEMI complicated by CS carries a substantial in-hospital mortality risk (22.3%).
  • Prolonged CPR, persistently low SBP, and elevated lactates are key mortality predictors.
  • While rare, CS progression portends a worse prognosis and increased complications.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
70
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Imbalances in Cardiac Output01:23

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K